Testosterone Cypionate Injection, USP, 2000 mg/10 mL, 1 mL Vial, Single-Dose, Rx only, Mfd. for: Wilshire Pharmaceuticals, Inc. Atlanta, GA 30328. NDC 52536-625-01
Published November 6, 2019 · Recall initiated: September 27, 2019
Summary
FDA records drug Class III recall D-0167-2020, published November 6, 2019 and initiated September 27, 2019. Recalling firm: Arbor Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 67934 units; Lot: lot# 23803.002B, Exp 07/2020; 23803.005A, Exp 01/2021. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling:Label Mix-up: Shipper Carton labelled Testosterone Cypionate Injection, USP, 200mg/mL, 1 ml single-dose vials, found to contain shelf cartons labelled as Testosterone Cypionate Injection USP, 200mg/mL, 10 ml multi-dose vials which contain Testosterone Cypionate Injection USP, 200mg/mL,1mL single-does vials
What to do
Voluntary: Firm initiated · E-Mail
Get an email if TESTOSTERONE CYPIONATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- TESTOSTERONE CYPIONATE
- Manufacturer
- Arbor Pharmaceuticals Inc.
- Distributor
- Nationwide in the US
- Lot
- lot# 23803.002B, Exp 07/2020; 23803.005A, Exp 01/2021
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATestosterone Cypionate Injection, USP, CIII, 200mg per mL, Rx only, 1mL Single-Dose Vial, Distributed by EugiaApril 23, 2025
- FDATestosterone Cypionate Injection, USP, CIII, 200 mg/mL, packaged in: a) 10 mL multiple-dose vials (NDCApril 12, 2023
- FDATestosterone Cypionate Injection, USP, 200mg/mL, CIII, Rx only, 1mL Single-dose vial, Distributed by: SunJuly 20, 2022
- FDATestosterone Cypionate Injection, USP, 200mg/ml, Rx Only, One Single-dose vial, Distributed by: SunJuly 13, 2022
- FDAAVKARE Ranitidine Hydrochloride Capsules 150 mg 500 Capsules Rx Only NDC 42291-735-50 UPC 342291735507November 6, 2019
- FDAIbuprofen Oral Suspension USP, 100 mg/5 mL, One Pint, (473 mL), Rx only, Manufactured by: Taro PharmaceuticalsNovember 6, 2019
Questions about this recall
Was Testosterone Cypionate Injection, USP, 2000 mg/10 mL, 1 mL Vial, Single-Dose, Rx only, Mfd. for: Wilshire Pharmaceuticals, Inc. Atlanta, GA 30328. NDC 52536-625-01 recalled?
Yes. FDA published recall D-0167-2020 on November 6, 2019. Reported hazard: Labeling:Label Mix-up: Shipper Carton labelled Testosterone Cypionate Injection, USP, 200mg/mL, 1 ml single-dose vials, found to contain shelf cartons labelled as Testosterone Cypionate Injection USP, 200mg/mL, 10 ml multi-dose vials which contain Testosterone Cypionate Injection USP, 200mg/mL,1mL single-does vials
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: TESTOSTERONE CYPIONATE.